Liquid Biopsy, Cancer Genomics
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
32
NCT02767752
Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer
Phase: Phase 2
Role: Collaborator
Start: Nov 30, 2016
Completion: Jul 31, 2018
NCT03320525
Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN)
Phase: Phase 1
Start: Nov 29, 2017
Completion: Sep 25, 2018
Loading map...